Table 2.

Plasma Lipid, Lipoprotein and Apolipoprotein Biomarkers Among CETP Variants in Patients Treated with Statin

	Lipid Biomarkers†
	Total cholesterol (mmol/L)	LDL-C (mmol/L)	HDL-C (mmol/L)	Triglycerides (mmol/L)	Apolipoprotein-AI (mg/dL)	Apolipoprotein-B (mg/dL)
CETP rs3764261 (C>A)
CC (n = 126)	4.87 (4.37–5.34)	2.71 (0.74)	1.26 (1.06–1.55)	1.98 (1.22–2.44)	157.6 (24.2)	90.1 (79.3–106.0)
CA (n = 140)	4.90 (4.45–5.31)	2.74 (0.87)	1.40 (1.19–1.70)	1.52 (1.11–2.03)	164.3 (27.2)	86.7 (76.5–102.0)
AA (n = 33)	5.10 (4.75–5.53)	3.02 (0.61)	1.53 (1.39–1.88)	1.40 (1.13–1.78)	171.7 (25.6)	86.0 (77.6–99.5)
p-value	0.180	0.118	<0.001	0.004	0.010	0.597
CETP rs708272 (G>A)
GG (n = 101)	4.84 (4.39–5.31)	2.72 (0.78)	1.32 (1.11–1.57)	1.79 (1.18–2.27)	158.6 (25.7)	86.4 (78.2–99.8)
GA (n = 153)	4.95 (4.43–5.54)	2.77 (0.83)	1.35 (1.10–1.66)	1.73 (1.16–2.44)	161.6 (26.6)	88.6 (78.0–108.5)
AA (n = 45)	4.92 (4.51–5.21)	2.79 (0.72)	1.50 (1.30–1.77)	1.32 (1.05–1.53)	173.0 (23.2)	87.7 (76.5–94.6)
p-value	0.617	0.852	0.006	0.001	0.008	0.398
CETP rs12149545 (G>A)
GG (n = 193)	4.95 (4.43–5.37)	2.77 (0.77)	1.35 (1.14–1.61)	1.66 (1.16–2.28)	161.7 (25.6)	88.9 (78.8–101.0)
GA (n = 97)	4.84 (4.42–5.34)	2.74 (0.86)	1.37 (1.17–1.72)	1.58 (1.13–2.27)	162.3 (27.0)	87.1 (75.9–107.0)
AA (n = 9)	4.95 (4.60–5.44)	2.69 (0.65)	1.71 (1.27–1.98)	1.37 (1.09–1.85)	175.3 (27.2)	84.2 (75.1–98.9)
p-value	0.756	0.937	0.119	0.516	0.312	0.666

Notes: ^†The parametric variables are given as mean (standard deviation) and the nonparametric variables are given as median (interquartile range). All biochemical measures are given in Système International units; conversions to conventional units are as follows: cholesterol (mg/dL), multiply by 38.6; triglycerides (mg/dL), multiply by 88.5.

Abbreviations: LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.